Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis
about
Prime-boost approaches to tuberculosis vaccine developmentIncreased B and T Cell Responses in M. bovis Bacille Calmette-Guérin Vaccinated Pigs Co-Immunized with Plasmid DNA Encoding a Prototype Tuberculosis AntigenAnalysis of the vaccine potential of plasmid DNA encoding nine mycolactone polyketide synthase domains in Mycobacterium ulcerans infected miceThe order of prime-boost vaccination of neonatal calves with Mycobacterium bovis BCG and a DNA vaccine encoding mycobacterial proteins Hsp65, Hsp70, and Apa is not critical for enhancing protection against bovine tuberculosis.Assessment of immune response to repeat stimulation with BCG vaccine using in vitro PBMC model.Enhancing the protective efficacy of Mycobacterium bovis BCG vaccination against tuberculosis by boosting with the Mycobacterium tuberculosis major secretory protein.Coexpression of interleukin-12 chains by a self-splicing vector increases the protective cellular immune response of DNA and Mycobacterium bovis BCG vaccines against Mycobacterium tuberculosisVaccination of guinea pigs with DNA encoding the mycobacterial antigen MPB83 influences pulmonary pathology but not hematogenous spread following aerogenic infection with Mycobacterium bovisImproved tuberculosis DNA vaccines by formulation in cationic lipids.The secreted lipoprotein, MPT83, of Mycobacterium tuberculosis is recognized during human tuberculosis and stimulates protective immunity in miceMapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis.On the use of DNA vaccines for the prophylaxis of mycobacterial diseases.Intranasal boosting with an adenovirus-vectored vaccine markedly enhances protection by parenteral Mycobacterium bovis BCG immunization against pulmonary tuberculosis.Next generation: tuberculosis vaccines that elicit protective CD8+ T cellsDeveloping an improved vaccine against tuberculosis.A DNA prime-Mycobacterium bovis BCG boost vaccination strategy for cattle induces protection against bovine tuberculosis.New vaccines against tuberculosis.Increasing the Vaccine Potential of Live M. bovis BCG by Coadministration with Plasmid DNA Encoding a Tuberculosis Prototype Antigen.Vaccines for other neonatal infections: neonatal BCG vaccination against tuberculosis.Tuberculosis vaccine development: research, regulatory and clinical strategies.DNA vaccines against mycobacterial diseases.Heterologous boost vaccines for bacillus Calmette-Guérin prime immunization against tuberculosis.Immune response to dna vaccine expressing transferrin binding protein a gene of Pasteurella multocida.Ag85B DNA vaccine suppresses airway inflammation in a murine model of asthmaViral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.Mycobacterium tuberculosis culture filtrate proteins plus CpG Oligodeoxynucleotides confer protection to Mycobacterium bovis BCG-primed mice by inhibiting interleukin-4 secretion.The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs.Application of mycobacterial proteomics to vaccine design: improved protection by Mycobacterium bovis BCG prime-Rv3407 DNA boost vaccination against tuberculosis.A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice.Accelerated induction of mycobacterial antigen-specific CD8+ T cells in the Mycobacterium tuberculosis-infected lung by subcutaneous vaccination with Mycobacterium bovis bacille Calmette-Guérin.Immunogenicity of Mycobacterium tuberculosis antigens in Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle.Immunogenicity and protective efficacy of tuberculosis DNA vaccines combining mycolyl-transferase Ag85A and phosphate transport receptor PstS-3.Heterologous boosting with recombinant VSV-846 in BCG-primed mice confers improved protection against Mycobacterium infection.Protection from bacterial infection by a single vaccination with replication-deficient mutant herpes simplex virus type 1.Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guérin.Induction of Specific CD8 T Cells against Intracellular Bacteria by CD8 T-Cell-Oriented Immunization Approaches.Epitope-specific CD4+, but not CD8+, T-cell responses induced by recombinant influenza A viruses protect against Mycobacterium tuberculosis infection.Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing Mycobacterial antigen 85A and Mycobacterium bovis BCGDNA vaccine encoding ESAT-6 enhances the protective efficacy of BCG against Mycobacterium tuberculosis infection in mice.The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
P2860
Q27024526-3C4686ED-053F-4057-B05B-27A77000C9F9Q27302995-A3FF9F0C-FA18-43F6-BCC3-68C752FB8A2CQ28538249-E1721CC6-8FCF-4CDA-8637-D4C87EE3C7C3Q33883504-531C17A2-52C8-4583-9E7B-6B9CC694AE6CQ33933553-71EC987F-A350-459F-804D-F788322C7826Q33946552-05E93D47-A5ED-4859-86F5-6CCC80CF31CFQ34120701-C8065742-8AFF-4113-B9B1-986A83A57652Q34120896-60DD94CF-4289-414F-B31F-55D3DDE12A41Q34126930-12FF23FF-C13E-445E-B03B-6639AFD8B80BQ34261521-2D766918-3F05-4A27-8DF8-ACE615C8A799Q34527217-3AD4D718-54FD-4B07-9BF6-99565FD8EEF5Q34852418-21243C47-AAB8-4051-9973-1472F281996EQ34975770-A8908E8A-6403-4326-814F-43FF2B17CC33Q35099708-C0AB49BA-D50F-4CA0-9D29-883CC180F9CFQ35791774-369E5EAE-9C1E-49A2-B5CC-3E9323C2CFDAQ35801915-55FDEB6B-0D80-4859-9D6A-CB9DA615F2ADQ35823534-57647B47-1A2E-4958-920C-985E88511C02Q35826596-A3377DC1-AF87-409E-B57B-80EAA8054069Q35843610-02EAD6A7-AA65-4A09-8657-3CA7ED5A3B43Q35873788-A7833CF4-75CC-4DB1-BB62-28552F1413DFQ36895737-864ED0E2-456D-45B9-927B-2413D7ED6DA2Q36899073-5BE9E0F9-0688-419C-8032-2656312EA515Q37162315-E2BA03FF-884A-41DA-8869-FBA85221314AQ37268382-40772EED-548B-41A0-A7D8-50DCB4A0FB28Q37274874-93C8DACB-4440-472E-A08D-AD84A51E90AEQ37451207-A12D3A30-3455-4BF1-A00A-93F6692F65D3Q37582822-7EF9A421-1F71-49F9-85C5-678175E99544Q37582879-8D013E20-DC73-4AAD-BBB5-290BA0E8EF8BQ37623702-F8A85F4C-3FE7-4786-9AEF-2A381B8DC134Q38899894-79708C53-2F43-497D-BA88-F095E79761ADQ40304602-C8EB57D5-31EF-4AA7-93C0-B947000BB43DQ40308913-4FC9DA6D-5C82-4248-A590-4FE0CCED445DQ40411515-2C57D03A-572D-434F-9CAF-C8680E063DA4Q40521843-D61F823D-C9F2-4EE7-ACAC-C1F5182EF1FFQ40545644-58983EE5-EF2A-4DDE-890E-7F5DFB2A6064Q40730694-AEA54036-E2C2-4B5E-A674-D388ECB05137Q41645299-87E439E3-3876-4735-9647-9767E6FCFE31Q41908519-5EAF2BCC-11A4-4EE7-97BE-D7AD5DE6D53FQ44437540-0AB81044-2D44-4A41-877D-CCB2468A9E86Q44831422-237904A5-2194-4690-B712-F6BBFD4ED850
P2860
Priming by DNA immunization augments protective efficacy of Mycobacterium bovis Bacille Calmette-Guerin against tuberculosis
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Priming by DNA immunization au ...... te-Guerin against tuberculosis
@ast
Priming by DNA immunization au ...... te-Guerin against tuberculosis
@en
Priming by DNA immunization au ...... te-Guerin against tuberculosis
@nl
type
label
Priming by DNA immunization au ...... te-Guerin against tuberculosis
@ast
Priming by DNA immunization au ...... te-Guerin against tuberculosis
@en
Priming by DNA immunization au ...... te-Guerin against tuberculosis
@nl
prefLabel
Priming by DNA immunization au ...... te-Guerin against tuberculosis
@ast
Priming by DNA immunization au ...... te-Guerin against tuberculosis
@en
Priming by DNA immunization au ...... te-Guerin against tuberculosis
@nl
P2093
P2860
P1476
Priming by DNA immunization au ...... te-Guerin against tuberculosis
@en
P2093
P2860
P304
P356
10.1128/IAI.69.6.4174-4176.2001
P407
P50
P577
2001-06-01T00:00:00Z